ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 61.11 percent increase over losses of $(0.36) per share from the same period last year. The company reported $719.000 thousand in sales this quarter. This is a 163.37 percent increase over sales of $273.000 thousand the same period last year.
精彩评论